<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04939155</url>
  </required_header>
  <id_info>
    <org_study_id>TD-ME-001</org_study_id>
    <nct_id>NCT04939155</nct_id>
  </id_info>
  <brief_title>Methylation Effects of COV-19 Infection and Vaccinations</brief_title>
  <official_title>Measuring the DNA Methylation Effects From COVID-19 Infection and COVID-vaccinations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TruDiagnostic</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>TruDiagnostic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective non-randomized clinical study of 60 patients total to assess the&#xD;
      effects of SARS-CoV-2 infection and the SARS-CoV-2 vaccination. This study will have 2 arms&#xD;
      evaluating the epigenomes of patients pre and post-exposure to one of the interventions. The&#xD;
      first arm of the study will analyze 40 patients' epigenomes whose DNA methylation was&#xD;
      examined pre and post SARS-CoV-2 infection. The second arm of this study is analyzing 20&#xD;
      patients' epigenomes whose DNA methylation was examined pre and post-injection of the&#xD;
      SARS-CoV-2 vaccine.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 10, 2021</start_date>
  <completion_date type="Anticipated">March 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Methylation age clock testing</measure>
    <time_frame>Change from baseline after COVID-19 infection</time_frame>
    <description>The DNA clocks that will be used to precisely measure aging is TruAge Biological Age test, which estimates biological age vs. chronological age</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Methylation age clock testing</measure>
    <time_frame>Change from baseline after COVID-19 mRNA vaccination</time_frame>
    <description>The DNA clocks that will be used to precisely measure aging is TruAge Biological Age test, which estimates biological age vs. chronological age</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall state of health</measure>
    <time_frame>Change from baseline after COVID-19 infection</time_frame>
    <description>Questionnaire assessing overall health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall state of health</measure>
    <time_frame>Change from baseline after COVID-19 mRNA vaccination</time_frame>
    <description>Questionnaire assessing overall health</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Patients infected with SARS-CoV-2</arm_group_label>
    <description>The first part of this study looks at the methylation patterns in individuals who have a baseline test taken of their DNA methylation patterns in their epigenome and then a follow-up test after they contracted SARS-CoV-2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients who have received an mRNA vaccination</arm_group_label>
    <description>The second part of the study looks at the methylation patterns in individuals who have a baseline test taken of their DNA methylation patterns in their epigenome and then a follow-up test after SARS CoV-2 mRNA vaccine injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>SARS-CoV-2 mRNA vaccine</intervention_name>
    <description>mRNA vaccine for COVID</description>
    <arm_group_label>Patients who have received an mRNA vaccination</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects that are healthy individuals and of any sex, ethnicity, and anyone above the age&#xD;
        of 18 years old.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects that are healthy individuals and of any sex, ethnicity, and anyone above the&#xD;
             age of 18 years old.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>TruDiagnostic</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bonek K, Roszkowski L, Massalska M, Maslinski W, Ciechomska M. Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment. Cells. 2021 Feb 4;10(2). pii: 323. doi: 10.3390/cells10020323. Review.</citation>
    <PMID>33557301</PMID>
  </reference>
  <reference>
    <citation>Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020 May;20(5):269-270. doi: 10.1038/s41577-020-0308-3.</citation>
    <PMID>32273594</PMID>
  </reference>
  <reference>
    <citation>Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&amp;D. Science. 2020 May 29;368(6494):948-950. doi: 10.1126/science.abc5312. Epub 2020 May 11.</citation>
    <PMID>32393526</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 14, 2021</study_first_submitted>
  <study_first_submitted_qc>June 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2021</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

